Latest Pharmaceutical Acquisitions News

Page 2 of 2
Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.
Ada Torres
Ada Torres
21 May 2025
Mayne Pharma has announced the expiration of the US antitrust waiting period, a critical step forward in Cosette Pharmaceuticals' proposed acquisition. The transaction now moves closer to completion, pending other regulatory and shareholder approvals.
Ada Torres
Ada Torres
7 May 2025

Browse the archive

Full archive